A common 1.6 mb Y-chromosomal inversion predisposes to subsequent deletions and severe spermatogenic failure in humans

Author:

Hallast Pille12ORCID,Kibena Laura1,Punab Margus34,Arciero Elena2,Rootsi Siiri5,Grigorova Marina1,Flores Rodrigo5,Jobling Mark A6,Poolamets Olev3,Pomm Kristjan3,Korrovits Paul3,Rull Kristiina147,Xue Yali2,Tyler-Smith Chris2,Laan Maris1ORCID

Affiliation:

1. Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia

2. Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, Cambridge, United Kingdom

3. Andrology Unit, Tartu University Hospital, Tartu, Estonia

4. Institute of Clinical Medicine, University of Tartu, Tartu, Estonia

5. Institute of Genomics, Estonian Biocentre, University of Tartu, Tartu, Estonia

6. Department of Genetics & Genome Biology, University of Leicester, Leicester, United Kingdom

7. Women’s Clinic, Tartu University Hospital, Tartu, Estonia

Abstract

Male infertility is a prevalent condition, affecting 5–10% of men. So far, few genetic factors have been described as contributors to spermatogenic failure. Here, we report the first re-sequencing study of the Y-chromosomal Azoospermia Factor c (AZFc) region, combined with gene dosage analysis of the multicopy DAZ, BPY2, and CDYgenes and Y-haplogroup determination. In analysing 2324 Estonian men, we uncovered a novel structural variant as a high-penetrance risk factor for male infertility. The Y lineage R1a1-M458, reported at >20% frequency in several European populations, carries a fixed ~1.6 Mb r2/r3 inversion, destabilizing the AZFc region and predisposing to large recurrent microdeletions. Such complex rearrangements were significantly enriched among severe oligozoospermia cases. The carrier vs non-carrier risk for spermatogenic failure was increased 8.6-fold (p=6.0×10−4). This finding contributes to improved molecular diagnostics and clinical management of infertility. Carrier identification at young age will facilitate timely counselling and reproductive decision-making.

Funder

Estonian Research Council

Wellcome Trust

European Regional Development Fund

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3